Cargando…
Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease
BACKGROUND: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031633/ https://www.ncbi.nlm.nih.gov/pubmed/31617239 http://dx.doi.org/10.1002/jcla.23051 |
_version_ | 1783499417250168832 |
---|---|
author | Gargouri, Bochra Mseddi, Malek Mnif, Fatma Abid, Mohamed Attia, Hamadi Lassoued, Saloua |
author_facet | Gargouri, Bochra Mseddi, Malek Mnif, Fatma Abid, Mohamed Attia, Hamadi Lassoued, Saloua |
author_sort | Gargouri, Bochra |
collection | PubMed |
description | BACKGROUND: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme in patients with Graves' disease (GD) and healthy controls in a comparative way. METHODS: The CAT activity was evaluated via spectrophotometric method. Using enzyme‐linked immunosorbent assay, the reactivities of autoantibody toward native, malondialdehyde (MDA) and hydrogen peroxide (H(2)O(2)) modified CAT were evaluated in plasmas of patients and controls. RESULTS: Reduced CAT activity was found in patients compared with controls (P < .05). It was proved that levels of IgG antibodies against MDA‐modified CAT were higher than against unmodified ones (P < .001). No changes were found for the reactivities to H(2)O(2)‐modified CAT. Positive correlation was found between the reactivity to MDA‐modified CAT and the triiodothyronine level (P < .001, r = .6). CONCLUSION: Our findings incriminate the MDA in the autoantibodies reactivity to oxidatively modified CAT leading to a disturbed oxidative profile and/or the progression of GD pathology. |
format | Online Article Text |
id | pubmed-7031633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70316332020-02-27 Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease Gargouri, Bochra Mseddi, Malek Mnif, Fatma Abid, Mohamed Attia, Hamadi Lassoued, Saloua J Clin Lab Anal Research Articles BACKGROUND: Oxidative stress is associated with several autoimmune disorders and oxidative modification of proteins that may result in autoimmune response. This study aims to evaluate the catalase (CAT) activity and the autoimmune response against the native CAT and the oxidatively modified enzyme in patients with Graves' disease (GD) and healthy controls in a comparative way. METHODS: The CAT activity was evaluated via spectrophotometric method. Using enzyme‐linked immunosorbent assay, the reactivities of autoantibody toward native, malondialdehyde (MDA) and hydrogen peroxide (H(2)O(2)) modified CAT were evaluated in plasmas of patients and controls. RESULTS: Reduced CAT activity was found in patients compared with controls (P < .05). It was proved that levels of IgG antibodies against MDA‐modified CAT were higher than against unmodified ones (P < .001). No changes were found for the reactivities to H(2)O(2)‐modified CAT. Positive correlation was found between the reactivity to MDA‐modified CAT and the triiodothyronine level (P < .001, r = .6). CONCLUSION: Our findings incriminate the MDA in the autoantibodies reactivity to oxidatively modified CAT leading to a disturbed oxidative profile and/or the progression of GD pathology. John Wiley and Sons Inc. 2019-10-16 /pmc/articles/PMC7031633/ /pubmed/31617239 http://dx.doi.org/10.1002/jcla.23051 Text en © 2019 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Gargouri, Bochra Mseddi, Malek Mnif, Fatma Abid, Mohamed Attia, Hamadi Lassoued, Saloua Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease |
title | Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease |
title_full | Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease |
title_fullStr | Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease |
title_full_unstemmed | Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease |
title_short | Oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with Graves’ disease |
title_sort | oxidative stress enhances the immune response to oxidatively modified catalase enzyme in patients with graves’ disease |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031633/ https://www.ncbi.nlm.nih.gov/pubmed/31617239 http://dx.doi.org/10.1002/jcla.23051 |
work_keys_str_mv | AT gargouribochra oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease AT mseddimalek oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease AT mniffatma oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease AT abidmohamed oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease AT attiahamadi oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease AT lassouedsaloua oxidativestressenhancestheimmuneresponsetooxidativelymodifiedcatalaseenzymeinpatientswithgravesdisease |